Business

This comes roughly a year after Walgreens pledged to invest $1 billion in equity and convertible debt in VillageMD over a three-year time frame. 

This week's top stories include U.S. Anesthesia Partners alleging UnitedHealthcare is "like a boa constrictor squeezing USAP-TX from all sides" and Bright Health looking to strengthen its foothold in the telemedicine market.

Also: Pre-conception genetic-testing startup Orchid completes seed round, and Canvas Medical scores $17M for its physician practice platform.   

Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution. 

The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.

This comes just a week after news broke that Bright Health plans IPO. 

The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.   

The company designed a tool to automate bills and give patients additional insights to their charges. 

The funds will be used to develop the firm’s non-invasive blood sensing technology.